P506: CLINICAL VALIDATION OF THE NORDIC GUIDELINES FOR GERMLINE TESTING IN MYELOID NEOPLASMS: RESULTS FROM A MULTI-CENTER PROSPECTIVE COHORT STUDY

• Bianca Tesi,
• Anna Eriksson,
• Berivan Baskin,
• Vladimir Lazarevic,
• Stefan Deneberg,
• Martin Höglund,
• Linda Fogelstrand,
• Johanna Ungerstedt,
• Tatjana Pandzic,
• Magnus Tobiasson,
• Hege Gravdahl Garelius,
• Ekaterina Kuchinskaya,
• Fredrik Persson,
• Helena Ågerstam,
• Bertil Uggla,
• Helene Hallböök,
• Thoas Fioretos,
• Ann-Charlotte Thuresson,
• Sören Lehmann,
• Claes Ladenvall,
• Gisela Barbany,
• Lovisa Vennström,
• Elisabeth Ejerblad,
• Lucia Cavelier,
• Jörg Cammenga,
• Martin Jädersten,
• Eva Hellström Lindberg,
• Panagiotis Baliakas

Affiliations

Bianca Tesi

1 Karolinska University Hospital, Department of Clinical Genetics, Stockholm, Sweden

Anna Eriksson

3 Uppsala University, Department of Medical Sciences, Uppsala, Sweden

Berivan Baskin

4 Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden

Vladimir Lazarevic

5 Skåne University Hospital, Department of Hematology, Oncology and Radiation Physics, Lund, Sweden

Stefan Deneberg

6 Karolinska University Hospital, Department of Hematology, Stockholm, Sweden

Martin Höglund

3 Uppsala University, Department of Medical Sciences, Uppsala, Sweden

Linda Fogelstrand

8 Sahlgrenska University Hospital, Department of Clinical Chemisty, Gothenburg, Sweden

Johanna Ungerstedt

6 Karolinska University Hospital, Department of Hematology, Stockholm, Sweden

Tatjana Pandzic

4 Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden

Magnus Tobiasson

6 Karolinska University Hospital, Department of Hematology, Stockholm, Sweden

Hege Gravdahl Garelius

10 Sahlgrenska University Hospital, Department of Specialist Medicine, Gothenburg, Sweden

Ekaterina Kuchinskaya

11 Linköping University, Department of Clinical Genetics, Department of Clinical Experimental Medicine, Linköping, Sweden

Fredrik Persson

12 Sahlgrenska University Hospital, Department of Clinical Genetics & Genomics, Gothenburg, Sweden

Helena Ågerstam

13 Lund University, Division of Clinical Genetics, Department of Laboratory Medicine, Lund, Sweden

Bertil Uggla

14 Örebro University, Section of Hematology, Department of Medicine, Faculty of Medicine and Health, Örebro, Sweden

Helene Hallböök

3 Uppsala University, Department of Medical Sciences, Uppsala, Sweden

Thoas Fioretos

13 Lund University, Division of Clinical Genetics, Department of Laboratory Medicine, Lund, Sweden

Ann-Charlotte Thuresson

4 Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden

Sören Lehmann

3 Uppsala University, Department of Medical Sciences, Uppsala, Sweden

Claes Ladenvall

4 Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden

Gisela Barbany

1 Karolinska University Hospital, Department of Clinical Genetics, Stockholm, Sweden

Lovisa Vennström

15 Sahlgrenska University Hospital, Section of Hematology and Coagulation, Gothenburg, Sweden

Elisabeth Ejerblad

3 Uppsala University, Department of Medical Sciences, Uppsala, Sweden

Lucia Cavelier

1 Karolinska University Hospital, Department of Clinical Genetics, Stockholm, Sweden

Jörg Cammenga

5 Skåne University Hospital, Department of Hematology, Oncology and Radiation Physics, Lund, Sweden

Martin Jädersten

6 Karolinska University Hospital, Department of Hematology, Stockholm, Sweden

Eva Hellström Lindberg

6 Karolinska University Hospital, Department of Hematology, Stockholm, Sweden

Panagiotis Baliakas

4 Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden